Financial distress negatively impacts well-being, satisfaction of breast cancer patients

December 11, 2020

CHICAGO (December 11, 2020): Financial toxicity among breast cancer patients is independently associated with worse psychological well-being following a mastectomy or lumpectomy operation. However, even small improvements in financial pressure associated with treatment-related costs can lead to better mental well-being and higher patient satisfaction with breast reconstruction, according to an "article in press" published on the website of the Journal of the American College of Surgeons ahead of print.

Women undergoing breast cancer surgery are vulnerable to financial stress due to the expensive and extended duration of treatment. High out-of-pocket costs can take a major toll on a patient's health, leading to financial toxicity (the harm or stress a person experiences due to the unaffordability of his or her medical care).

"Breast cancer therapy is highly sensitive to patient preferences, so right from the start patients are expected to make a lot of decisions and each one has trade-offs," said lead study author Christopher J. Coroneos, MD, MSc, an assistant professor of plastic surgery at McMaster University in Ontario, Canada. "There is a unique set of decisions that a patient has to make--undergoing a lumpectomy versus mastectomy, undergoing chemotherapy, adjuvant therapy and radiation, and then breast reconstruction--that is why breast cancer is different from other cancers."

Even so, timely and in-depth discussions between providers and patients about the cost of cancer care are uncommon. This is the first study to examine the connection between financial distress and quality-of-life outcomes (overall and condition specific) in women who undergo surgery for breast cancer, according to the authors.

Researchers analyzed the results of three self-reported surveys and medical record data for 532 women who underwent lumpectomy or mastectomy at The University of Texas MD Anderson Cancer Center in Houston. Patients were aged 18 years and older and had completed the surveys within 18 months of their breast cancer operation. Most of the patients (64 percent) underwent breast reconstruction. The median annual household income was reported between $80,000 and $120,000, well above the national average.

Using the COST (COmprehensive Score for financial Toxicity) questionnaire, researchers identified patients in financial distress. In addition, participants responded to questions from the BREAST-Q and SF-12 surveys, designed to assess quality of life, mental well-being, and physical satisfaction after undergoing breast reconstruction; a lower score represents a worse outcome.

After adjusting for multiple confounding factors, the analysis showed that financial toxicity, as reflected in a lower COST score, was strongly associated with lower BREAST-Q and SF-12 scores, indicating worse outcomes. Further, COST had the largest impact on one particular outcome, psychological well-being, with a one unit increase in COST correlated with a 0.89 unit increase in the psychological well-being score.

"Even a small change in financial toxicity translates to an important change in psychosocial well-being," Dr. Coroneos said. The data also showed a positive relationship between patients' psychological well-being and their own perceived satisfaction with the outcome of their breast reconstruction.

The study builds on previous findings examining the link between financial toxicity and quality of life. However, this study is important because it uses validated patient reported outcome measures for the analysis.

"In this world of patient-centered outcomes and value-based care, there are two takeaway points from our study. First, for populations at high risk for financial toxicity, deliberations around treatment costs are incredibly important. Second, early intervention in instances of self-reported financial toxicity will be a key element of maximizing patient-reported outcomes in breast cancer surgery. This is because financial toxicity really does dampen the high-quality, patient-centered outcomes we are capable of delivering," said study senior author Anaeze C. Offodile II, MD, MPH, an assistant professor of plastic surgery at The University of Texas MD Anderson Cancer Center, Houston.

Currently, the authors are conducting a prospective multi-center trial, reproducing this work in a variety of settings. They hope to get a more in-depth understanding of how economic well-being impacts quality of life outcomes in breast cancer surgery (timing, triggers and duration), and ultimately, how interventions that improve the economic well-being of cancer patients could lead to improvements in care.

"What clinicians have to do with these study results is to consider the financial reserve patients have when discussing breast cancer management." Dr. Coroneos said. "From a research perspective, integrating the financial risk and patient reported outcomes can inform decision-making models, and is especially important in vulnerable populations."
-end-
Study coauthors are Brian Chin, MD, MSc, from McMaster University, Ontario, Canada; Yu-Li Lin, MS, Chris Sidley-Gibbons, PhD, Malke Asaad, MD, Stefanos Boukovalas, MD, Margaret S. Roubaud, MD, FACS, Makesha Miggins, MD, FACS, and Donald P. Baumann, MD, FACS, all from The University of Texas MD Anderson Cancer Center, Houston.

"FACS" designates that a surgeon is a Fellow of the American College of Surgeons.

This study was supported by the University Cancer Foundation via the Sister Institution Network Fund (SINF) at the University of Texas MD Anderson Cancer Center.


Citation: Correlation between Financial Toxicity, Quality-of-Life and Patient Satisfaction in an Insured Population of Breast Cancer Surgical Patients: A Single Institution Retrospective Study. Journal of the American College of Surgeons.

About the American College of Surgeons

The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and improve the quality of care for all surgical patients. The College is dedicated to the ethical and competent practice of surgery. Its achievements have significantly influenced the course of scientific surgery in America and have established it as an important advocate for all surgical patients. The College has more than 82,000 members and is the largest organization of surgeons in the world. For more information, visit http://www.facs.org.

American College of Surgeons

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.